Literature DB >> 9009235

Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.

B A Lessey1, A O Ilesanmi, A J Castelbaum, L Yuan, S G Somkuti, K Chwalisz, P G Satyaswaroop.   

Abstract

Endometrial progesterone receptors (PR) are regulated by both estrogen (E2) and progesterone (P) and mediate the expression of specific endometrial proteins. Ishikawa cells are a well-differentiated human endometrial adenocarcinoma cell line, with both estrogen receptors (ER) and PR, regulated in a manner similar to that of normal endometrium. Immunohistochemical and biochemical analyses demonstrate that the concentration of PR is increased by E2 priming and decreased by subsequent treatment with P. Scatchard plot analysis showed a K(d) of 1 nM. On the basis of biochemical analysis, PR concentrations reached approximately 1400 fmol/mg cytosol protein in cells after treatment with E2 (10(-8) M) for 4 days. Immunoprecipitation and Western blot studies revealed the presence of both the 116 kDa and 81 kDa proteins with multiple isoforms of the high molecular weight (MW) protein. Northern blot analysis demonstrated transcriptional control of PR by steroid treatment. These studies demonstrate the coordinate regulation of all PR mRNA species. The functionality of Ishikawa PR was demonstrated by the expression of alpha1beta1 integrin in response to E2 plus P, at the level of transcription and translation. This effect was blocked by the addition of the anti-progestin, RU-486. These studies reconfirm that the Ishikawa cell line is an excellent model for the study of hormonally regulated events in the human endometrial epithelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9009235     DOI: 10.1016/s0960-0760(96)00103-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  20 in total

1.  Isolation, immortalization, and initial characterization of uterine cell lines: an in vitro model system for the porcine uterus.

Authors:  G Wang; G A Johnson; T E Spencer; F W Bazer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10.

Authors:  Patrick J Troy; Gaurang S Daftary; Catherine N Bagot; Hugh S Taylor
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  Dose- and Time-Dependent Transcriptional Response of Ishikawa Cells Exposed to Genistein.

Authors:  Jorge M Naciff; Zubin S Khambatta; Gregory J Carr; Jay P Tiesman; David W Singleton; Sohaib A Khan; George P Daston
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

4.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

5.  A novel role for the AAA ATPase spastin as a HOXA10 transcriptional corepressor in Ishikawa endometrial cells.

Authors:  Gaurang S Daftary; Amy M Tetrault; Elisa M Jorgensen; Jennifer Sarno; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2011-07-14

6.  Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.

Authors:  Emily Berry; Jennifer L Hardt; Jon Clardy; John R Lurain; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-11-28       Impact factor: 5.482

7.  HOXA10 regulates endometrial GABAA {pi} receptor expression and membrane translocation.

Authors:  Homayoun Sadeghi; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

8.  HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.

Authors:  H S Taylor; A Arici; D Olive; P Igarashi
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

9.  Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.

Authors:  Megan Buechel; Anindya Dey; Shailendra Kumar Dhar Dwivedi; Aleia Crim; Kai Ding; Roy Zhang; Priyabrata Mukherjee; Kathleen N Moore; Liangxian Cao; Arthur Branstrom; Marla Weetall; John Baird; Resham Bhattacharya
Journal:  Mol Cancer Ther       Date:  2018-07-19       Impact factor: 6.261

10.  Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle.

Authors:  Anthony H Taylor; Muna Guzail; May Wahab; John R Thompson; Farook Al-Azzawi
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.